Oncolytic Virotherapy is a form of cancer treatment that uses genetically modified viruses to target and destroy cancer cells. It is a form of gene therapy, as the viruses are modified to carry therapeutic genes that can be used to treat cancer. The viruses are designed to specifically target cancer cells, while leaving healthy cells unharmed. This form of therapy has been used to treat a variety of cancers, including melanoma, breast cancer, and lung cancer. Oncolytic Virotherapy has the potential to be a more effective form of cancer treatment than traditional treatments, such as chemotherapy and radiation. It is also less invasive and has fewer side effects. Additionally, it can be used in combination with other treatments, such as immunotherapy, to further enhance its effectiveness. The Oncolytic Virotherapy market is growing rapidly, as more companies are investing in the development of new treatments. Companies such as Amgen, Merck, and Pfizer are leading the way in the development of new treatments. Other companies, such as Oncolytics Biotech, ImmunoVaccine, and Vyriad, are also investing in the development of new treatments. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
